Both the FOXO3a WT and TM mutants increased the percentage of cells in G1 in the CML CD34+ cells, again this was not further enhanced by dasatinib in FOXO3a TM-transfected cells (Supporting Information Fig. S3E). Here, CD34 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.